🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

4,838 results for “SP” Clear

  1. Tirofiban hydrochloride sodium chloride injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Branch Atheromatous Disease

    approved small molecule completed

    1 trial

  2. Tirzepatide

    The First People's Hospital of Lianyungang

    Type 2 Diabetes Mellitus

    approved small molecule active

    1 trial

  3. Tislelizumab

    The First People's Hospital of Lianyungang

    Advanced NSCLC

    approved small molecule active

    1 trial

  4. Tislelizumab + cisplatin + paclitaxel

    The First People's Hospital of Lianyungang

    Esophageal Squamous Cell Carcinoma

    approved small molecule active

    1 trial

  5. Tocilizumab

    Shanghai Zhongshan Hospital

    Takayasu Arteritis

    approved mab active

    1 trial

  6. Tocilizumab

    The First People's Hospital of Lianyungang

    Multiple Myeloma

    approved small molecule active

    1 trial

  7. Tofacitinib and Acitretin Capsules.

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Primary Cutaneous Amyloidosis

    approved small molecule active

    1 trial

  8. Topical Anesthetic

    Hospital Authority, Hong Kong

    Radial Artery Spasm

    approved small molecule active

    1 trial

  9. Tranexamic Acid

    The First People's Hospital of Lianyungang

    Postpartum Hemorrhage， Cesarean Section

    approved small molecule active

    1 trial

  10. Transepicardial with Transseptal CD 133+ Implantation

    Hospital Authority, Hong Kong

    Coronary Artery Disease

    approved mab completed

    1 trial

  11. Trastuzumab Rezetecan

    The First People's Hospital of Lianyungang

    Breast Cancer

    approved small molecule active

    1 trial

  12. Treatment group

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hypertension

    approved small molecule completed

    1 trial

  13. Trimebutine 100 MG

    Hospital Authority, Hong Kong

    Helicobacter Pylori Infection

    approved small molecule completed

    1 trial

  14. Trimetazidine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Heart Disease

    approved small molecule active

    1 trial

  15. Triple antithrombotic therapy

    The First People's Hospital of Lianyungang

    Acute Coronary Syndrome (ACS)

    approved small molecule active

    1 trial

  16. Triple combination therapy group

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Type 2 Diabetes Mellitus

    approved small molecule completed

    1 trial

  17. Triptergium Wilfordii

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Psoriasis Vulgaris

    approved small molecule active

    1 trial

  18. Typhoid Vi vaccine

    International Peace Maternity and Child Health Hospital

    Typhoid

    approved mab completed

    1 trial

  19. Urapidil Accord 5 mg/ml solución inyectable y para perfusión EFG, Trandate 5mg/ml Solution for Injection, Fenilefrina Altan 0,1 mg/ml solución inyectable y para perfusión.

    The George Institute

    Acute Ischemic Stroke

    approved small molecule active

    1 trial

  20. Ursodeoxycholic acid combined with total glucosides of paeony

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis

    approved small molecule active

    1 trial

  21. VAB-7

    The First People's Hospital of Lianyungang

    Helicobacter Pylori

    approved small molecule active

    1 trial

  22. Valproic acid

    Hospital Authority, Hong Kong

    Drug Resistant Epilepsy

    approved small molecule active

    1 trial

  23. Vancomycin

    The First People's Hospital of Lianyungang

    Blood Stream Infections

    approved small molecule active

    1 trial

  24. Vardenafil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Erectile Dysfunction

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources